First Trust Advisors LP Charles River Laboratories International, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 73,695 shares of CRL stock, worth $14.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

73,695

Previous 72,281 1.96%

Holding current value

$14.7 Million

Previous $14.9 Million 2.77%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $265,775 - $346,840	1,414 Added 1.96%	73,695 $14.5 Million
Q2 2024 Aug 13, 2024	SELL	$206.39 - $268.73 $4.85 Million - $6.32 Million	-23,503 Reduced 24.54%	72,281 $14.9 Million
Q1 2024 May 13, 2024	SELL	$203.52 - $273.43 $44.8 Million - $60.2 Million	-219,988 Reduced 69.67%	95,784 $26 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $4.18 Million - $6.07 Million	-25,421 Reduced 7.45%	315,772 $74.6 Million
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $6.56 Million - $7.34 Million	-33,728 Reduced 9.0%	341,193 $66.9 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $12.3 Million - $14.1 Million	67,112 Added 21.8%	374,921 $78.8 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $2.22 Million - $3.01 Million	11,586 Added 3.91%	307,809 $62.1 Million
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $5.74 Million - $7.28 Million	29,098 Added 10.89%	296,223 $64.5 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $13.9 Million - $19 Million	75,942 Added 39.72%	267,125 $52.6 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $317,013 - $469,627	1,553 Added 0.82%	191,183 $40.9 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $23.3 Million - $33.1 Million	-91,371 Reduced 32.52%	189,630 $53.8 Million
Q4 2021 Feb 08, 2022	SELL	$351.38 - $448.68 $7.74 Million - $9.88 Million	-22,017 Reduced 7.27%	281,001 $106 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $8.25 Million - $10.1 Million	-22,135 Reduced 6.81%	303,018 $125 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $11.2 Million - $14.1 Million	-38,059 Reduced 10.48%	325,153 $120 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $11.5 Million - $13.8 Million	-46,089 Reduced 11.26%	363,212 $105 Million
Q4 2020 Feb 02, 2021	SELL	$222.0 - $252.62 $28.8 Million - $32.7 Million	-129,564 Reduced 24.04%	409,301 $102 Million
Q3 2020 Nov 05, 2020	SELL	$175.56 - $226.45 $8.32 Million - $10.7 Million	-47,389 Reduced 8.08%	538,865 $122 Million
Q2 2020 Jul 22, 2020	BUY	$118.84 - $189.72 $945,372 - $1.51 Million	7,955 Added 1.38%	586,254 $102 Million
Q1 2020 May 06, 2020	BUY	$98.9 - $178.34 $12.2 Million - $21.9 Million	122,897 Added 26.99%	578,299 $73 Million
Q4 2019 Feb 03, 2020	SELL	$126.05 - $152.76 $15.6 Million - $18.9 Million	-123,675 Reduced 21.36%	455,402 $69.6 Million
Q3 2019 Nov 04, 2019	SELL	$125.07 - $143.67 $43.5 Million - $50 Million	-347,847 Reduced 37.53%	579,077 $76.7 Million
Q2 2019 Jul 30, 2019	SELL	$123.4 - $148.55 $21.1 Million - $25.4 Million	-171,242 Reduced 15.59%	926,924 $132 Million
Q1 2019 May 09, 2019	SELL	$104.82 - $146.73 $129,243 - $180,918	-1,233 Reduced 0.11%	1,098,166 $160 Million
Q4 2018 Feb 07, 2019	BUY	$105.09 - $137.23 $25.3 Million - $33 Million	240,437 Added 27.99%	1,099,399 $124 Million
Q3 2018 Oct 25, 2018	BUY	$112.11 - $134.54 $34.9 Million - $41.8 Million	310,975 Added 56.75%	858,962 $116 Million
Q2 2018 Aug 02, 2018	SELL	$102.37 - $117.25 $4.11 Million - $4.71 Million	-40,177 Reduced 6.83%	547,987 $61.5 Million
Q1 2018 Apr 23, 2018	BUY	$98.19 - $115.2 $4.05 Million - $4.75 Million	41,196 Added 7.53%	588,164 $62.8 Million
Q4 2017 Feb 08, 2018	SELL	$100.43 - $118.09 $749,107 - $880,833	-7,459 Reduced 1.35%	546,968 $59.9 Million
Q3 2017 Oct 24, 2017	BUY	$96.72 - $109.26 $53.6 Million - $60.6 Million	554,427	554,427 $59.9 Million

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Charles River Laboratories International, Inc. Transaction History